Addiction

Consumer products giant Johnson & Johnson was a "kingpin" company that helped fuel the most devastating public health crisis in Oklahoma history, the AG argued Monday.

Dozens of prosecutors across the country are now backing Safehouse.

The state, where 5,400 people fatally overdosed in 2017, was chosen in hopes it could offer models for both hard-hit rural and urban regions.

A new study of Delaware overdose deaths in 2018 found 52% of people who died had visited the emergency room within three months of their death.

The move coincides with the first major update on the emergency response to the opioid crisis since the last homeless encampment was closed in Kensington.

The Centers for the Disease Control and Prevention found opioids played a role in nearly 48,000 deaths in the U.S. in 2017.

Six months in, opponents say a smoking ban at Philadelphia inpatient addiction treatment centers is a barrier to getting started for some. Others leave early.

One hundred seventy-four pharmacies participated in what the state believed was the largest single-day U.S. public distribution of the opioid-reversing drug.

The WHO notified lawmakers that it will discontinue two publications on prescribing opioids in response to allegations that the pharmaceutical industry influenced the reports.

One bill in the package imposes a 7-day limit on opioid painkiller prescriptions for all adults.

New Jersey officials distributed 20,000 free naloxone packs to pharmacies, and said Tuesday’s event was a pilot program that could be expanded in the future.

Jails face increasing pressures as they house large numbers of mentally ill and addicted inmates. But the policies that contributed to this problem are decades in the making.

Deaths connected to suicide, drugs, and alcohol are soaring among millennials nationwide, and hitting Pennsylvania especially hard.

Such a deal could funnel billions of dollars to American communities struggling with the addiction crisis while restoring stability to one of America's biggest industries.

Pennsylvania Senate may tighten rules on doctors using buprenorphine.